News
Tylenol, Kenvue
Digest more
Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company ...
With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...
Inventiva named Jason Campagna as president of R&D and chief medical officer, and Martine Zimmermann as EVP of regulatory affairs and quality assurance. Evolent named Dr. David Lim as chief clinical ...
Kenvue (KUVE) has named Kirk Perry, a current director, as its interim CEO, effective immediately. Concurrently, Thibaut Mongon has left the company and resigned from the Kenvue Board. Perry, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback